Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression
- PMID: 1344289
- DOI: 10.1177/096368979200100106
Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression
Abstract
Cultured-expanded rat marrow-derived mesenchymal cells differentiate into osteoblasts when combined with a porous calcium phosphate delivery vehicle and subsequently implanted in vivo. In this study, the effects of ceramic pretreatment with the cell-binding proteins fibronectin and laminin on the osteogenic expression of marrow-derived mesenchymal cells were assessed by scanning electron microscopy, [3H]-thymidine-labeled cell quantitation, and histological evaluation of bone formation. Scanning electron microscopic observations showed that marrow-derived mesenchymal cells rapidly spread and attach to both fibronectin- or laminin-adsorbed ceramic surfaces but retain a rounded morphology on untreated ceramic surfaces. Quantitation of [3H]-thymidine labeled cells demonstrated that laminin and fibronectin preadsorbed ceramics retain approximately double the number of marrow-derived mesenchymal cells than do untreated ceramics harvested 1 wk postimplantation. Histological observations indicate that the amount of time required to first detect osteogenesis was shortened significantly by pretreatment of the ceramic with either fibronectin or laminin. Fibronectin- and laminin-coated ceramic composite samples were observed to contain bone within 2 wk postimplantation, while in untreated ceramic the earliest observation of bone was at 4 wk postimplantation. A comparison was made of the initial cell-loading, in vivo cell retention characteristics, and rate of osteogenesis initiation of marrow-derived mesenchymal cells on two types of ceramic with different pore structure and chemical composition, with and without preadsorption with fibronectin or laminin. "Biphasic" ceramics contain randomly distributed pores 200-400 microns in diameter, and "coral-based" ceramics have continuous pores of approximately 200 microns in diameter. Laminin or fibronectin preadsorption significantly increases the number of cells retained in all ceramic test groups by day 7 postimplantation. In addition, by day 7 postimplantation, the biphasic ceramics retain a significantly greater number of cells for all test groups than do coral-based ceramics. The biphasic ceramics consistently have more specimens positive for bone with the identical cell-loading conditions used throughout this study. These results indicate that the retention of cells within the ceramic is an important factor for optimization of marrow mesenchymal cell initiated bone formation. The retention of cells within ceramics is augmented by the adsorption of the cell-binding proteins laminin and fibronectin, but this effect varies depending on ceramic pore structure and/or chemical composition.
Similar articles
-
Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin.J Oral Implantol. 1993;19(2):106-15; discussion 136-7. J Oral Implantol. 1993. PMID: 8246297
-
Hyaluronic acid-based polymers as cell carriers for tissue-engineered repair of bone and cartilage.J Orthop Res. 1999 Mar;17(2):205-13. doi: 10.1002/jor.1100170209. J Orthop Res. 1999. PMID: 10221837
-
The osteogenic potential of culture-expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic blocks.Clin Orthop Relat Res. 1991 Jan;(262):298-311. Clin Orthop Relat Res. 1991. PMID: 1984928
-
Stem cell technology and bioceramics: from cell to gene engineering.J Biomed Mater Res. 1999;48(6):913-27. doi: 10.1002/(sici)1097-4636(1999)48:6<913::aid-jbm22>3.0.co;2-0. J Biomed Mater Res. 1999. PMID: 10556859 Review.
-
Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering.Expert Opin Biol Ther. 2014 Feb;14(2):197-208. doi: 10.1517/14712598.2014.866086. Epub 2013 Dec 6. Expert Opin Biol Ther. 2014. PMID: 24308323 Review.
Cited by
-
Defining human mesenchymal stem cell efficacy in vivo.J Inflamm (Lond). 2010 Oct 25;7:51. doi: 10.1186/1476-9255-7-51. J Inflamm (Lond). 2010. PMID: 20974000 Free PMC article.
-
Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine.In Vitro Cell Dev Biol Anim. 2014 Mar;50(3):251-60. doi: 10.1007/s11626-013-9702-5. Epub 2013 Oct 23. In Vitro Cell Dev Biol Anim. 2014. PMID: 24150687
-
Review of additive manufactured tissue engineering scaffolds: relationship between geometry and performance.Burns Trauma. 2018 Jul 3;6:19. doi: 10.1186/s41038-018-0121-4. eCollection 2018. Burns Trauma. 2018. PMID: 29988731 Free PMC article. Review.
-
Transcriptome Sequencing Analysis of lncRNA and mRNA Expression Profiles in Bone Nonunion.Oxid Med Cell Longev. 2022 Oct 12;2022:9110449. doi: 10.1155/2022/9110449. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36275904 Free PMC article.
-
In vitro comparison of different carrier materials with rat bone marrow MSCs.Clin Oral Investig. 2014 Jan;18(1):247-59. doi: 10.1007/s00784-013-0956-9. Epub 2013 Mar 6. Clin Oral Investig. 2014. PMID: 23463148
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical